Bank of Montreal
ATXI

Bank of Montreal’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

Bank of Montreal’s Portfolio ATXI Stock Details ATXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Hold
0
– -$1K – 5053
2021
Q1 		– Sell
-1
Closed -$6.87K – 5011
2020
Q4 		$7K Buy
+1
New +$5.24K ﹤0.01% 4730
2020
Q3 		– Hold
0
– – – 4599
2020
Q2 		– Hold
0
– – – 4428

Other funds holding ATXI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Bank of Montreal's ATXI Position: Q2 2021 in Review

Bank of Montreal held its Avenue Therapeutics, Inc. Common Stock (ATXI) position steady in Q2 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5053.

Bank of Montreal first reported a position in ATXI in Q4 2020 and has held it in 1 quarter since. The position peaked at $7K in Q4 2020. 24 funds tracked by Wall St. Rank hold ATXI as of Q2 2021.

  • Bank of Montreal held 0 shares of Avenue Therapeutics, Inc. Common Stock worth $0 as of Q2 2021.
  • Bank of Montreal left its Avenue Therapeutics, Inc. Common Stock share count unchanged in Q2 2021.
  • Avenue Therapeutics, Inc. Common Stock made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2021, its #5053 holding.
  • Bank of Montreal first reported a position in Avenue Therapeutics, Inc. Common Stock in Q4 2020 and has held it in 1 quarter since.
  • Bank of Montreal's Avenue Therapeutics, Inc. Common Stock position peaked at $7K in Q4 2020.
  • 24 funds tracked by Wall St. Rank held Avenue Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.